Beacon Pharmaceuticals PLC (DSE:BEACONPHAR)
Bangladesh · Delayed Price · Currency is BDT 89.20
+0.50 (0.56%)
At close: Nov 4, 2026
Beacon Pharmaceuticals Ratios and Metrics
Market cap in millions BDT. Fiscal year is July - June.
Millions BDT. Fiscal year is Jul - Jun.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 3, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
| 20,605 | 24,463 | 35,528 | 56,595 | 59,667 | 28,552 | |
Market Cap Growth | -18.17% | -31.14% | -37.22% | -5.15% | 108.98% | 103.62% |
Enterprise Value | 29,645 | 30,968 | 45,350 | 62,791 | 63,025 | 30,523 |
Last Close Price | 89.20 | 103.72 | 148.05 | 234.30 | 245.53 | 116.74 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 3, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
PE Ratio | 10.61 | 25.85 | 68.19 | 111.01 | 63.81 | 33.08 |
PS Ratio | 1.25 | 1.95 | 3.32 | 6.65 | 7.44 | 4.01 |
PB Ratio | 2.49 | 3.67 | 5.83 | 9.53 | 10.04 | 5.33 |
P/TBV Ratio | 2.49 | 3.68 | 5.86 | 9.54 | 10.04 | 5.33 |
P/FCF Ratio | 11.92 | 31.42 | - | - | - | - |
P/OCF Ratio | 9.21 | 15.29 | - | 91.11 | 55.14 | 145.26 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 3, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
EV/Sales Ratio | 1.80 | 2.47 | 4.24 | 7.38 | 7.86 | 4.29 |
EV/EBITDA Ratio | 7.37 | 10.44 | 19.36 | 41.92 | 30.64 | 17.47 |
EV/EBIT Ratio | 8.58 | 13.27 | 24.99 | 64.13 | 38.97 | 22.42 |
EV/FCF Ratio | 17.15 | 39.78 | - | - | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 3, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Debt / Equity Ratio | 1.22 | 1.53 | 1.69 | 1.25 | 0.64 | 0.47 |
Debt / EBITDA Ratio | 2.57 | 3.44 | 4.41 | 4.98 | 1.86 | 1.43 |
Debt / FCF Ratio | 6.32 | 13.11 | - | - | - | - |
Net Debt / Equity Ratio | 1.17 | 1.49 | 1.64 | 1.17 | 0.55 | 0.40 |
Net Debt / EBITDA Ratio | 2.48 | 3.36 | 4.27 | 4.66 | 1.60 | 1.23 |
Net Debt / FCF Ratio | 6.04 | 12.80 | -7.84 | -5.85 | -5.15 | -18.43 |
Asset Turnover | - | 0.65 | 0.64 | 0.67 | 0.83 | 0.91 |
Inventory Turnover | - | 1.96 | 2.14 | 2.15 | 2.40 | 2.99 |
Quick Ratio | 0.46 | 0.39 | 0.36 | 0.36 | 0.54 | 0.82 |
Current Ratio | 1.61 | 1.54 | 1.37 | 1.20 | 1.38 | 1.87 |
Return on Equity (ROE) | - | 14.84% | 8.66% | 8.58% | 16.55% | 17.29% |
Return on Assets (ROA) | - | 7.61% | 6.76% | 4.81% | 10.45% | 10.83% |
Return on Invested Capital (ROIC) | 14.39% | 10.38% | 6.84% | 6.64% | 13.98% | 14.31% |
Return on Capital Employed (ROCE) | 25.70% | 21.10% | 18.80% | 13.70% | 26.30% | 23.70% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 3, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Earnings Yield | 9.43% | 3.87% | 1.47% | 0.90% | 1.57% | 3.02% |
FCF Yield | 8.39% | 3.18% | -3.59% | -2.11% | -1.07% | -0.41% |
Dividend Yield | 2.35% | 1.98% | 1.30% | 0.65% | 0.62% | 1.21% |
Payout Ratio | 15.05% | 36.67% | 70.93% | 72.78% | 39.95% | 6.88% |
Total Shareholder Return | 2.35% | 1.98% | 1.30% | 0.65% | 0.62% | 1.21% |